Both in Biotechnology
Ginkgo Bioworks Holdings vs 4D Molecular Therapeutics
Over the past year DNA returned −9.6% and FDMT returned +73.5%; their daily moves had a correlation of 0.29.
DNA −9.6% FDMT +73.5%Growth of $1, one year, split-adjusted
| Metric | DNA | FDMT |
|---|---|---|
| Price | $11.96 | $14.49 |
| Market cap | $805.4M | $800.5M |
| Today | +14.34% | −0.48% |
| 1 month | +71.8% | −1.2% |
| 6 months | +118.2% | +69.1% |
| Year to date | +43.9% | +93.2% |
| 1 year | +4.0% | +72.7% |
| Revenue growth (YoY) | −48.5% | +25106.7% |
| Gross margin | 91.5% | 100.0% |
| Net margin | −231.7% | −1929.0% |
| P/E (TTM) | — | — |
| Price / sales | 7.2× | 8.7× |
| Net cash | $302.2M | $341.7M |
| Dividend yield | — | — |
| Volatility (60d) | 100.6% | 68.4% |
| Short % of float | 16.9% | 27.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).